Doxorubicin Hydrochloride - NDC Database (Page 3)
82 records found
Page:
45963-733 Nov 01, 2014
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Actavis Pharma, Inc.
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Actavis Pharma, Inc.
47335-049 Feb 05, 2013
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injectable, Liposomal by Sun Pharma Global Fze
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injectable, Liposomal by Sun Pharma Global Fze
47335-050 Feb 05, 2013
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injectable, Liposomal by Sun Pharma Global Fze
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injectable, Liposomal by Sun Pharma Global Fze
49315-008 Sep 14, 2020
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injectable, Liposomal by Cadila Healthcare Limited
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injectable, Liposomal by Cadila Healthcare Limited
49315-009 Sep 14, 2020
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injectable, Liposomal by Cadila Healthcare Limited
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injectable, Liposomal by Cadila Healthcare Limited
53150-314 Apr 30, 2013
Doxorubicin Hydrochloride 20 mg/10ml Intravenous Injection by Amneal-agila, LLC
Doxorubicin Hydrochloride 20 mg/10ml Intravenous Injection by Amneal-agila, LLC
53150-315 Apr 30, 2013
Doxorubicin Hydrochloride 50 mg/25ml Intravenous Injection by Amneal-agila, LLC
Doxorubicin Hydrochloride 50 mg/25ml Intravenous Injection by Amneal-agila, LLC
53150-317 Apr 30, 2013
Doxorubicin Hydrochloride 200 mg/100ml Intravenous Injection by Amneal-agila, LLC
Doxorubicin Hydrochloride 200 mg/100ml Intravenous Injection by Amneal-agila, LLC
53150-320 Apr 30, 2013
Doxorubicin Hydrochloride 10 mg/5ml Intravenous Injection by Amneal-agila, LLC
Doxorubicin Hydrochloride 10 mg/5ml Intravenous Injection by Amneal-agila, LLC
55390-241 May 20, 1996
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
55390-242 Feb 11, 1997
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
55390-243 May 20, 1996
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
55390-245 May 20, 1996
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
55390-246 May 20, 1996
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
55390-247 May 20, 1996
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
55390-248 May 20, 1996
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
62756-826 Feb 20, 2012
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Sun Pharmaceutical Industries Limited
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Sun Pharmaceutical Industries Limited
62756-827 Feb 20, 2012
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Sun Pharmaceutical Industries Limited
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Sun Pharmaceutical Industries Limited
63323-101 Jun 14, 2000
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Fresenius Kabi USA, LLC
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Fresenius Kabi USA, LLC
Page:
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.